Clinical Trials on Lung Adenocarcinoma in Germany

Total 3854 results

Institut für Klinische Krebsforschung IKF GmbH...
Bristol-Myers Squibb; Eisai GmbH

Completed

Immunotherapy With Nivolumab in Combination With Lenvatinib for Advanced Stage Hepatocellular Carcinoma

Advanced Hepatocellular Carcinoma

Germany
Broncus Medical Inc

Terminated

Continuing Evaluation of the LungPoint ATV System

Lung Cancer

Germany
Technical University of Munich

Completed

Targeted Natural Killer (NK) Cell Based Adoptive Immunotherapy for the Treatment of Patients With Non-Small Cell Lung Cancer (NSCLC) After Radiochemotherapy (RCT)

NSCLC Stage IIIA/B

Germany
Enrico De Toni

Recruiting

Sequential or Up-front Triple Treatment With Durvalumab, Tremelimumab and Bevacizumab for Non-resectable Hepatocellular Carcinoma (HCC) Patients (MONTBLANC)

Hepatocellular Carcinoma

Germany
Boehringer Ingelheim

Terminated

Investigation of the Effect of Nintedanib on the Pharmacokinetics of a Combination of Ethinylestradiol and Levonorgestrel in Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

Germany
Michael Koller
Medical University of Graz; National Taiwan University Hospital; Oslo University... and other collaborators

Completed

Update of the EORTC QLQ-LC13 Quality of Life Questionnaire

Lung Cancer

Germany
University Hospital Muenster
Eli Lilly and Company; Bayer

Terminated

Study in Patients With Advanced Non-Small Cell Lung Cancer Treated With Pemetrexed and Carboplatin Plus or Minus Sorafenib (PECASO)

Carcinoma, Non-Small-Cell Lung

Germany
Lung Cancer Group Cologne

Unknown

Erlotinib and Sequential Positron Emission Tomography (PET) in Advanced Non Small Cell Lung Cancer (NSCLC) (ERLOPET)

Carcinoma, Non-Small-Cell Lung

Germany
Eli Lilly and Company

Completed

Performance Status During Treatment With Pemetrexed in Patients With NSCLC (PERFORMANCE)

Non Small Cell Lung Cancer

Germany
Bayer

Terminated

Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment (SORAGO-HCC)

Hepatocellular Carcinoma

Germany
Klinikum Esslingen

Recruiting

Prospective Trial of Induction Immunotherapy in Locally Advanced or Oligometastatic NSCLC Without a Primary Curative Option (KOMPASSneo)

Carcinoma, Non-Small-Cell Lung

Germany
Merck KGaA, Darmstadt, Germany

Completed

Phase 2b Randomized Controlled Study of Tecemotide (L-BLP25) for Immunotherapy of NSCLC (Non-Small Cell Lung Cancer)

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

Germany
Deutsche Lungenstiftung e.V.
Hannover Medical School

Completed

Evaluation of the Role of Nocturnal Non-Invasive Ventilation in Pulmonary Rehabilitation

Pulmonary Disease, Chronic Obstructive

Germany
Klaus Kenn

Completed

Effects of Inpatient Pulmonary Rehabilitation on Frailty in Patients After Lung-Transplantation

Interstitial Lung Disease | COPD | Advanced Lung Disease

Germany
Institut für Klinische Krebsforschung IKF GmbH...
Roche Pharma AG; Thoraxklinik-Heidelberg gGmbH

Recruiting

NeoTRACK - Dissection of IO Efficacy in NSCLC by Longitudinal tracKing

Non-small Cell Lung Cancer

Germany
AstraZeneca

Completed

Investigation of the Effect of Oral Treatment With 100 mg AZD2423 in Subjects With Mild Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease | Lung Disease

Germany
Heidelberg University

Completed

Radiation Plus Cetuximab in Locally Advanced Non-Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Germany
Charite University, Berlin, Germany
Bristol-Myers Squibb; Pierre Fabre Pharma GmbH

Unknown

Study for Patients With Non Small Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Germany
University of Cologne

Completed

SORAVE - Sorafenib and Everolimus in Solid Tumors (SORAVE)

Non-Small Cell Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

Germany
University Hospital, Essen

Recruiting

Lung_Cancer_adaptive - Ethos

Lung Cancer

Germany
University Hospital Tuebingen
German Federal Ministry of Education and Research

Terminated

Fingerprint Characterization Tyrosine Kinase Inhibitors in Advanced HCC (e:Med-HCC-2)

Hepatocellular Carcinoma | Sorafenib

Germany
Aktion Bronchialkarzinom e.V.
Boehringer Ingelheim

Completed

An Dose Escalation Trial of Oral BIBF 1120 in Combination With Intravenous Carboplatin and Vinorelbine in Elderly Patients With Advanced Non-Small Cell Lung Cancer - Stage IV (VENUS-2) (VENUS-2)

Carcinoma, Non-Small-Cell Lung

Germany
Bayer

Completed

INSIGHT - Post Marketing Surveillance (INSIGHT)

Carcinoma, Hepatocellular

Germany, Austria
University Hospital Tuebingen
AstraZeneca

Recruiting

Influence of Biopsy Technique on Moleculargenetic Tumor Characterisation in NSCLC (PROFILER)

Carcinoma, Non-Small-Cell Lung | Pathology, Molecular

Germany
Boehringer Ingelheim

Completed

A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD)

Pulmonary Disease, Chronic Obstructive

Germany
Lung Clinic Hemer

Recruiting

Breath Analysis by Ion Mobility Spectrometry

Lung Diseases

Germany
GlaxoSmithKline

Completed

A Single Centre Randomized Study Evaluating The Safety And Tolerability Of GSK573719 In Healthy Volunteers

Pulmonary Disease, Chronic Obstructive

Germany
Hannover Medical School

Completed

Long-Term Study On Home Spirometry After Lung Transplantation

Death | Bronchiolitis Obliterans | Rejection | Lung Transplantation

Germany
Neovii Biotech

Completed

Phase II Study With Catumaxomab in Patients With Gastric Cancer After Neoadjuvant CTx and Curative Resection

Gastric Cancer | Gastric Adenocarcinoma

Austria, Spain, United Kingdom, Germany
Ludwig-Maximilians - University of Munich

Completed

Development a Method to Extract Antibiotic Concentration From Interstitial Lung and Epithelial Lining Fluid. (ALF)

Lung Transplantation

Germany
Hannover Medical School

Terminated

Twice Daily Versus Once Daily Administration of the Tacrolimus in Lung Transplantation

Lung Transplantation

Germany
Hoffmann-La Roche

Completed

A Study of Mycophenolate Mofetil (CellCept) in Lung Transplant Recipients

Lung Transplantation

Germany
AIO-Studien-gGmbH
AstraZeneca

Withdrawn

Randomized Phase II, Open-label Efficacy and Safety Study of Second-line Durvalumab Plus Tremelimumab Versus Platinum-based Chemotherapy Alone in Patients With NSCLC and First-line Checkpoint-inhibitor Therapy (Re-Check)

NSCLC Stage IV

Germany
Hannover Medical School

Terminated

Taxotere-Enoxaparin-(ENOXA)-Study

Non-small Cell Lung Cancer

Germany
Air Liquide SA
Asklepios Kliniken Hamburg GmbH

Terminated

Six-Minute Walk Test Comparing Helium/Oxygen to Nitrogen/Oxygen for COPD Rehabilitation (rehabilitate)

Pulmonary Disease, Chronic Obstructive

Germany
University Hospital Freiburg
Novartis; German Federal Ministry of Education and Research; Deutsche Krebshilfe...

Completed

Hector-Study to Evaluate the Efficacy of Octreotide in Patients With Inoperable Hepatocellular Carcinoma

Carcinoma, Hepatocellular

Germany
Hannover Medical School
Corscience, Inc.

Completed

Telecommunication Via Cell Phones During Post-Operative Treatment After Lung Transplantation (TeleTx)

Lung Transplantation

Germany
Pierre Fabre Pharma GmbH
iOMEDICO AG

Completed

Non-Interventional Study With Vinorelbine ORAL in Advanced Non-Small Cell Lung Carcinoma(NSCLC) and Metastatic Breast Cancer (MBC)

Metastatic Breast Cancer | Non Small Cell Lung Carcinoma

Germany
Universitätsmedizin Mannheim

Completed

Diagnostic and Therapeutic Approaches to Hyperinflation and Small Airway Disease in COPD

COPD

Germany
Drägerwerk AG & Co. KGaA
KKS Dresden

Completed

Assessment of the Capability of PulmoVista 500 to Continuously Monitor Changes of Ventilation Over Time

ARDS | Mechanical Ventilation | Single-lung Ventilation | ALI - Acute Lung Injury | Weaning From Ventilator

Germany
Universitätsmedizin Mannheim

Unknown

Evaluation of Novel Lung Function Parameters and Quantitative Computed Tomography (qCT) in Patients With Pulmonary Disease

Chronic Obstructive Pulmonary Disease | Interstitial Lung Disease | Bronchial Asthma

Germany
Technical University of Munich
Ludwig-Maximilians - University of Munich

Recruiting

All Eyes on PCS - Analysis of the Retinal Microvasculature in Patients With Post-COVID-19 Syndrome

Endothelial Dysfunction | Long Covid19 | Post COVID-19 Condition

Germany
Cantargia AB

Active, not recruiting

A First-in-Human Study of CAN04 in Patients With Solid Malignant Tumors (CANFOUR)

Colorectal Cancer | Non Small Cell Lung Cancer | Triple Negative Breast Cancer | Pancreatic Ductal Adenocarcinoma

Austria, Denmark, Germany, Belgium, Spain, Latvia, Netherlands, Lithuania, Estonia, Sweden, Norway
Amsterdam UMC

Recruiting

Prospective Endoscopic Follow-up of Patients With Submucosal and High Risk Mucosal Esophageal Adenocarcinoma (PREFER)

Barrett Esophagus | Submucosal Esophageal Adenocarcinoma | High-risk Mucosal Esophageal Adenocarcinoma

Netherlands, Belgium, Australia, United Kingdom, Germany, Switzerland
GlaxoSmithKline

Completed

Single Dose Escalation Study FTIM in Order to Assess Safety and Tolerability of GSK610677

Pulmonary Disease, Chronic Obstructive

Germany
GlaxoSmithKline

Completed

Assessment of Lung Function After Single Inhalations of a Bronchodilator From 2 Configurations a Dry Powder Inhaler.

Pulmonary Disease, Chronic Obstructive

Germany
LungenClinic Grosshansdorf
Research Center Borstel; German Center for Lung Research

Recruiting

Adult Arm of DZL All Age Asthma Cohort (ALLIANCE) (ALLIANCE)

Asthma

Germany
GlaxoSmithKline

Completed

Repeat Dose Study of Fluticasone Propionate/Salmeterol Versus Fluticasone Propionate + Salmeterol In Asthmatics

Asthma

Germany
GlaxoSmithKline

Completed

Evaluate the Effects of the Drug (SB-656933-AAA) on the Body After a Single Dose in Subjects Who Have Inhaled Ozone

Pulmonary Disease, Chronic Obstructive

Germany
Boehringer Ingelheim

Completed

Relative Bioavailability of of Olodaterol and Ketoconazole

Healthy | Pulmonary Disease, Chronic Obstructive

Germany

Clinical Trials on Lung Adenocarcinoma in Germany

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ecuador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations